MELISSA PATTERSON: Open Payments
NPI 1235671140 · GEORGETOWN, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$474 in 20 payments from 10 companies in 2025. Trend: 2023 $978 · 2024 $289 · 2025 $474
Food & beverage: $474
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $205 |
| Ardelyx, Inc. | 3 | $54 |
| Novo Nordisk Inc | 2 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| QOL Medical, LLC | 2 | $34 |
| Phathom Pharmaceuticals, Inc. | 2 | $26 |
| Intercept Pharmaceuticals, Inc. | 1 | $19 |
| Aimmune Therapeutics, Inc. | 1 | $19 |
| Madrigal Pharmaceuticals | 1 | $18 |
| Exact Sciences Corporation | 1 | $16 |
Products named: TREMFYA, IBSRELA, Wegovy, Sucraid, VOQUEZNA, OCALIVA, EOHILIA, ZENPEP.
Industry payments across SC — which companies pay providers there.
